Research Progress of Secreted Frizzled-related Proteins in Female Malignant Tumor

Research Progress of Secreted Frizzled-related Proteins in Female Malignant Tumor

The classical Wnt signaling pathway receptor inhibitors are composed of secreted frizzled-related proteins (SFRPs) and the Dickkopf family (Dkk). SFRPs inhibit wnt/β-catenin signaling by sequestering Wnt from the active receptor complexes. In tumor progression, epigenetic silencing of SFRPs promoter...

Full description

Bibliographic Details
Main Authors:	ZHANG Lixuan, LIU Chaoqi, LI Zhiying
Format:	Article
Language:	zho
Published:	Magazine House of Cancer Research on Prevention and Treatment 2020-03-01
Series:	Zhongliu Fangzhi Yanjiu
Subjects:	secreted frizzled-related proteins female malignant tumor cervical cancer ovarian cancer endometrial cancer breast cancer human trophoblast tumor
Online Access:	http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.0972.htm

Similar Items

THE POSSIBILITIES OF TREATMENT OF PATIENTS WITH MALIGNANT NEOPLASMS OF THE FEMALE REPRODUCTIVE SYSTEM WITH METASTATIC BRAIN LESION
by: A. M. Zaytsev, et al.
Published: (2016-09-01)

Wnt Signaling in Gynecologic Malignancies
by: Alexandra McMellen, et al.
Published: (2020-06-01)

Secreted Frizzled-Related Protein 1 as a Biomarker against Incomplete Age-Related Lobular Involution and Microcalcifications’ Development
by: Alisson Clemenceau, et al.
Published: (2020-09-01)

Secreted frizzled-related protein 4 expression is positively associated with responsiveness to Cisplatin of ovarian cancer cell lines <it>in vitro</it> and with lower tumour grade in mucinous ovarian cancers
by: Saran Uttara, et al.
Published: (2012-10-01)

Analysis of the role of Frizzled 2 in different cancer types
by: Miaomiao Zhou, et al.
Published: (2021-04-01)

Pattern of Pelvic Malignancies
by: Gul-e- Lala
Published: (2014-12-01)

Risk of female-specific cancers according to obesity and menopausal status in 2•7 million Korean women: Similar trends between Korean and Western women
by: In Sil Park, et al.
Published: (2021-06-01)

Synchronous Endometrial Malignant Mixed Mullerian Tumor and Ovarian High-Grade Serous Carcinoma: A Case Report and Review of Literature
by: Felix E. Menkiti, et al.
Published: (2019-07-01)

Normalization of abnormal plasma amino acid profile-based indexes in patients with gynecological malignant tumors after curative treatment
by: Yukio Suzuki, et al.
Published: (2018-10-01)

Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women
by: Anna Markowska, et al.
Published: (2020-11-01)

Urogynaecological Symptoms among Oncological Survivors and Impact of Oncological Treatment on Pelvic Floor Disorders and Lower Urinary Tract Symptoms. A Six-Month Follow-Up Study
by: Alicja Ziętek-Strobl, et al.
Published: (2020-08-01)

Targeted therapy with monoclonal antibodies: Do we observe progress in the management of female genital tract cancers?
by: Jacek R. Wilczyński, et al.
Published: (2018-04-01)

Evaluation of diagnostic accuracy of RMI and ROMA indices in comparison to HE4 and CA125 parameters for estimating the risk of malignancy of adnexal masses.
by: Afsaneh Tehranian, et al.
Published: (2021-05-01)

The Emerging Role of Adiponectin in Female Malignancies
by: Luca Gelsomino, et al.
Published: (2019-04-01)

Photodynamic Therapy in Gynecologic Malignancies: A Review of the Roswell Park Cancer Institute Experience
by: Paul C. Mayor, et al.
Published: (2016-09-01)

Functional Gene Expression Differentiation of the Notch Signaling Pathway in Female Reproductive Tract Tissues—A Comprehensive Review With Analysis
by: Magdalena Orzechowska, et al.
Published: (2020-12-01)

Cancer chemoprevention through Frizzled receptors and EMT
by: K. Sompel, et al.
Published: (2021-09-01)

The role of PARP inhibitors in the treatment of gynecologic malignancies
by: Raquel E. Reinbolt, et al.
Published: (2013-10-01)

The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication
by: Rosalba De Nola, et al.
Published: (2019-05-01)

p38β - MAPK11 and its role in female cancers
by: Periklis Katopodis, et al.
Published: (2021-06-01)

Immunotherapy in gynecological cancers
by: Domenica Lorusso, et al.
Published: (2021-02-01)

Comparison of Age- Standard Incidence Rate Trends of Gynecologic and Breast Cancer in Iran and Other Countries.
by: Maliheh Arab, et al.
Published: (2014-10-01)

Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies
by: Charles eKunos, et al.
Published: (2012-12-01)

Hereditary female cancers: Breast, ovarian, and endometrial
by: J. Morgan Tucker, III, et al.
Published: (2011-12-01)

Changes in Stem Cell Regulation and Epithelial Organisation during Carcinogenesis and Disease Progression in Gynaecological Malignancies
by: Paula Cunnea, et al.
Published: (2021-07-01)

A Malignant phyllodes Tumor of the Breast; Presentation of an Uncommon Case and Review of the Literature
by: Sumaiya Iqbal, et al.
Published: (2020-05-01)

Impact of the pathogenetic type of postmenopause on the occurrence of tumors of the female reproductive system
by: L. A. Ashrafyan, et al.
Published: (2014-07-01)

Dysregulated expression of long noncoding RNAs in gynecologic cancers
by: Elahe Seyed Hosseini, et al.
Published: (2017-06-01)

Associations between metabolic syndrome and gynecologic cancer
by: Da Yong Lee, et al.
Published: (2020-05-01)

Application of Laparoscopic Surgery in Gynecological Oncology
by: Wen-Chun Chang, et al.
Published: (2010-08-01)

The Effects of the Dietary and Nutrient Intake on Gynecologic Cancers
by: Masafumi Koshiyama
Published: (2019-07-01)

Synchronous Occurrence of Primary Neoplasms in the Uterus with Squamous Cell Carcinoma of the Cervix and Adenocarcinoma of the Endometrium
by: Cheng-Kuo Lin, et al.
Published: (2006-12-01)

KNDC1 Is a Predictive Marker of Malignant Transformation in Borderline Ovarian Tumors
by: Yu S, et al.
Published: (2020-01-01)

Hypoxic Non-Small-Cell Lung Cancer Cell-Secreted Exosomal microRNA-582-3p Drives Cancer Cell Malignant Phenotypes by Targeting Secreted Frizzled-Related Protein 1
by: Wang J, et al.
Published: (2020-10-01)

Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology
by: Olena Bilyk, et al.
Published: (2017-07-01)

An Exploration of Identity in Cancer Patients with Early Malignancies
by: Thiessen, Maclean
Published: (2017)

Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: results of an online survey
by: Annemie Luyckx, et al.
Published: (2020-07-01)

Gynaecological cancers coexisting with pregnancy – a literature review
by: Anna Skrzypczyk-Ostaszewicz, et al.
Published: (2016-08-01)

Expressions of sFRP1 and β-catenin in cervical cancer
by: Zhang Xiao-Yan, et al.
Published: (2012-01-01)

Correlation of SFRP2 and TPX2 expression with cancer cell apoptosis and EMT process in cervical cancer
by: Chao-Ban Zheng, et al.
Published: (2018-01-01)